CTI BioPharma (United States)
How to Contact CTI Biopharma
Phone
1-206-282-7100About CTI BioPharma
CTI BioPharma is a biopharmaceutical company focused on developing treatments for myeloproliferative neoplasms (MPNs) and other blood cancers. The company created VONJO (pacritinib), a JAK2 inhibitor approved for intermediate or high-risk myelofibrosis with low platelet counts. CTI’s hematology-oncology research addresses serious blood disorders with limited treatment options.
Medications
Medications Manufactured by CTI Biopharma
Experienced a Side Effect?
Report to Yellow Card (UK) or MedWatch (US)
Report to
👉
(UK)
👉
(US)
